Le Lézard
Classified in: Health
Subjects: RCL, PSF

Updated Food Recall Warning (Allergen) - (Debittered) Brewer's Yeast sold at The Stone Store Natural Foods recalled due to undeclared peanut


OTTAWA, Feb. 19, 2019 /CNW/ - The food recall warning issued earlier today has been updated to include additional product information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation.

The Stone Store Natural Foods is recalling (Debittered) Brewer's Yeast sold in bulk from the marketplace because it contains peanut which is not declared on the label. People with an allergy to peanut should not consume the recalled product described below.

The following product has been sold in bulk at The Stone Store Natural Foods, 14 Commercial Street, Guelph, Ontario.

Recalled product

 

Brand

Product

Size

UPC

Codes

None

(Debittered) Brewer's Yeast

Variable ? sold in bulk

None

All products sold from October 3, 2018 up to and including February 19, 2019

 

What you should do

Check to see if you have recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.

If you have an allergy to peanut, do not consume the recalled product as it may cause a serious or life-threatening reaction.

Background

This recall was triggered by a consumer complaint. The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing recalled product from the marketplace.

Reactions

There have been no reported reactions for the bulk (Debittered) Brewer's Yeast sold at The Stone Store Natural Foods.  However, there have been reported reactions associated with other recently recalled Brewers Yeast products.

More information

 

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: